Skip to main content
Clinical Trials/NCT00289107
NCT00289107
Completed
Not Applicable

Multi-center, Prospective, Clinical Evaluation of the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting vs P.F.C.® Sigma™ Cruciate Substituting Knee Primary Cases

DePuy Orthopaedics0 sites149 target enrollmentApril 1, 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
DePuy Orthopaedics
Enrollment
149
Primary Endpoint
Knee Society Score
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The study will evaluate the clinical performance of the rotating platform and fixed bearing implants through patient questionnaires, outcomes scoring and radiographic assessment.

Detailed Description

The study will evaluate the clinical performance of rotating platform and fixed bearing cruciate ligament substituting implants by obtaining a series of primary TKAS. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System or P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System and assignment is randomized.

Registry
clinicaltrials.gov
Start Date
April 1, 2001
End Date
November 1, 2007
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Osteoarthritis
  • Rheumatoid arthritis
  • Other inflammatory arthritis
  • Avascular necrosis (AVN) of bone
  • Post-Traumatic Arthritis
  • Juvenile Rheumatoid Arthritis

Exclusion Criteria

  • History of recent/active joint sepsis.
  • Charcot neuropathy.
  • Psycho-social disorders that would limit rehabilitation.
  • Greater than 75 years of age at the time of surgery.
  • Prior ipsilateral knee arthroplasty.
  • Metabolic disorders of calcified tissues, such as Paget's disease.
  • Severe diabetes mellitus.
  • Joint replacement due to autoimmune disorders.
  • Skeletal immaturity

Outcomes

Primary Outcomes

Knee Society Score

Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.

The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and \< 60 = poor.

Secondary Outcomes

  • Complications(On-going to end of study)
  • Medical Imaging(Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.)
  • Revisions(On-going to end of study)
  • SF-12 Patient Outcomes(Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.)

Similar Trials